Walk into a modern neurosurgical operating room, and you’ll see monitors displaying real-time imaging and robotic arms hovering with superhuman deftness.
In addition to decades of wisdom, the team is guided by data. But the most profound difference isn’t what patients see during surgery. It happens years earlier as neurosurgeons are trained.
We are living through a once-in-a-century reset of the apprenticeship model that has guided surgical education across many countries. The newest residents have mentored under accomplished surgeons, but they also have trained on lifelike simulations and

Among adolescents who vaped, those who had vs. had not been exposed to anti-vaping advertising and heard about e-cigarette or vaping product use-associated lung injury had higher odds for attempting to quit, according to study findings.
These data were published in BMC Public Health.
“For clinicians, one takeaway is that media and public health messages can really shape youth behavior,” Jijiang Wang, PhD, postdoctoral researcher at the UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science, told Healio.
“That means clinicians have an important role in reinforcing

Regardless of etiology, managing end-stage glenohumeral arthritis in patients who are young and very active remains a challenge.
The incidence of glenohumeral arthritis is lower in younger patients compared with senior patients, but function, pain and quality of life in highly productive years of life are significantly impacted.
Source: Matthew T. Glazier, DO; Michael H. Amini, MD; Andrew Razzano, MD; and Robert U. Hartzler, MD
In considering prosthetic shoulder arthroplasty for these patients, symptom relief, implant longevity and revision considerations should be weighed. Total shoulder

Researchers have found positive results in mouse models of severe allergy when treating them with an allergen-specific mRNA lipid nanoparticle therapeutic platform technology, according to a press release.
Results from this preclinical study, led by Marc E. Rothenberg, MD, PhD, director of the division of allergy and immunology at Cincinnati Children’s Hospital Medical Center, and Drew Weissman, MD, PhD, director of the Penn Institute for RNA Innovation at the University of Pennsylvania, suggest that this therapeutic strategy has potential to be a safer treatment option than allergy shots.